Frazier Life Sciences — 2018 Investments

4 investments dated 2018 · listed companies and verified rows first · show all

Mirum Pharmaceuticalsmirumpharma.com in 𝕏NASDAQ: MIRMNov 2018

Mirum Pharmaceuticals is a biopharmaceutical company that develops and delivers therapies for people living with rare diseases.

BiotechHealthtechSan Diego, US

Chris Peetz(Co-founder & Chief Executive Officer)in Eric Bjerkholt(Executive Officer)in Peter Radovich(Executive Officer)in

BoardMichael Grey(Director)Timothy Walbert(Director)

Board seat Patrick HeronPatrick J. Heron· per SEC Form D

Co-investorsChiesi Ventures Longitude Capital MESA VERDE VENTURE PARTNERS New Enterprise Associates (NEA)Pappas Capital RiverVest Venture Partners +4 more

Nabriva Therapeuticsnabriva.comJul 2018

BiotechDublin 1

Jennifer Schranz(Executive Officer)Axel Bolte(Director)Gary Sender(Executive Officer)Theodore Schroeder(Executive Officer, Director)Robert Crotty(Executive Officer)Colin Broom(Director)

Co-investorsAisling Capital EcoR1 Capital Longitude Capital MESA VERDE VENTURE PARTNERS Novartis Venture Fund

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Rafa Recida Therapeutics

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.